X @The Economist
Lilly(US:LLY) The Economist·2026-07-17 18:00The rise of GLP-1s has transformed the pharmaceutical company—and the industry as a whole. We explain why investors now value Lilly more like a tech giant than a drugmaker https://t.co/FeLKvk61gmIllustration: Carl Godfrey https://t.co/iZ2zKURcnK ...